Skip to main content
AAPA 2025 Annual Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Invitation Only
Invitation Only
Ticketed - Complimentary
Ticketed - Complimentary
Ticketed - Additional Fee Required
Ticketed - Additional Fee Required
Capturing for On Demand
Capturing for On Demand
Pharmacology
Pharmacology
National Health Priorities
National Health Priorities
Potential State Requirement
Potential State Requirement
Project Innovation
Project Innovation
PA Administrative Competencies
PA Administrative Competencies

ENDO-Endocrinology

Satellite Symposium: Outcome-Optimizing Synergies Between CGM and Self-Management in T2D: Focus on Pivotal Advantages in Patient Engagement and Improved Glycemic Metrics in Diabetes

Friday, May 16, 2025
6:00 PM – 8:00 PM  
Location: Colorado Convention Center, Mile High Ballroom 2

  • Ashlyn Smith, MMS, PA-C

    Adult Endocrine PA/President, American Society of Endocrine Physician Assistants
    Adjunct Assistant Professor, Midwestern University
    Scottsdale, AZ, United States

  • Eden Miller, DO

    Founder, Diabetes and Obesity Care LLC
    St. Charles Hospital
    Bend, OR, United States

  • James R. Gavin, MD, PhD

    Clinical Professor of Medicine, Emory University School of Medicine
    Clinical Professor of Medicine, Indiana University School of Medicine

This activity has been approved for 1.50 AAPA Category 1 CME credits.

Please click here to register to attend this session.

Using national authorities on primary care and diabetes management as faculty, this activity will focus on emerging digital, real time-, and patch-based technologies for continuous monitoring of glucose levels, to improve drug interventions for diabetes, minimize risks of hypoglycemia, maximize time in target range for blood glucose, optimize treatment interventions and drug titration, and improve and increase patient engagement. The expert faculty will discuss and communicate the evidentiary basis for CGM technologies, as well as strategies for how primary providers, including physician associates, should communicate, collaborate, and implement CGM-based technologies into their overall diabetes care plans.

This activity is supported by an educational grant from Abbott Diabetes Care.

This symposium is neither supported, sponsored, nor endorsed by AAPA.

Learning Objectives:

At the conclusion of this session, participants should be able to:
  • Outline and discuss the evidentiary basis for senor/patch-based CGM technologies, and how to best Implement CGM-based technologies into their overall diabetes care plans for patients with T1D and T2D
  • Analyze the rationale and evidence for recommending and facilitating adoption of technology-centric CGM monitoring and treatment plans using patch-and-reader-based technologies
  • Compare and contrast available CGM-facilitating monitoring technologies and pair such technologies with optimal patient profiles
  • Educate patients with diabetes about the rationale, evidence, and outcome- optimizing results associated with technology-based, patient-centric and physician-directed CGM monitoring strategies that can be used to effect optimal lifestyle, diet-, and pharmacology-based approaches to attaining guideline-based HA1c levels in patients with T1D and T2D
  • Identify which patients with diabetes are ideal candidates for a technology-based, patient-directed glucose monitoring system
  • Translate landmark clinical studies focused on CGM-based technologies to the front lines of clinical practice in the diabetes and primary care setting; and understand the translational implications of deploying sensor-based, CGM-based technologies as a foundational approach to improving outcomes in patients across the spectrum of diabetes